Prudential Financial’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.63M Sell
387,650
-98,230
-20% -$2.35M 0.01% 695
2025
Q4
$13M Sell
485,880
-423,540
-47% -$10.1M 0.02% 539
2025
Q3
$19.4M Buy
909,420
+223,943
+33% +$5.3M 0.02% 426
2025
Q2
$14.8M Buy
685,477
+330,876
+93% +$6.15M 0.02% 508
2025
Q1
$5.89M Buy
354,601
+100,640
+40% +$1.83M 0.01% 780
2024
Q4
$4.66M Buy
+253,961
New +$4.1M 0.01% 903
2024
Q3
Sell
-35,811
Closed -$582K 2707
2024
Q2
$582K Sell
35,811
-1,036,920
-97% -$16.7M ﹤0.01% 2104
2024
Q1
$19.8M Buy
1,072,731
+629,615
+142% +$15.6M 0.03% 446
2023
Q4
$13.9M Buy
443,116
+115,500
+35% +$2.76M 0.02% 545
2023
Q3
$6.83M Buy
327,616
+168,190
+105% +$4.57M 0.01% 779
2023
Q2
$3.82M Buy
159,426
+119,200
+296% +$2.65M 0.01% 1037
2023
Q1
$757K Buy
+40,226
New +$766K ﹤0.01% 1884
2022
Q4
Sell
-17,296
Closed -$283K 2591
2022
Q3
$283K Sell
17,296
-9,135
-35% -$148K ﹤0.01% 2329
2022
Q2
$373K Buy
26,431
+2,700
+11% +$50.4K ﹤0.01% 2247
2022
Q1
$575K Buy
23,731
+13,861
+140% +$335K ﹤0.01% 2139
2021
Q4
$230K Sell
9,870
-590
-6% -$11.9K ﹤0.01% 2497
2021
Q3
$174K Buy
10,460
+310
+3% +$5.97K ﹤0.01% 2494
2021
Q2
$248K Buy
+10,150
New +$229K ﹤0.01% 2382
2021
Q1
Sell
-56,075
Closed -$3M 2485
2020
Q4
$3M Buy
+56,075
New +$2.78M 0.01% 1234
2020
Q3
Sell
-123,354
Closed -$5.98M 2430
2020
Q2
$5.98M Sell
123,354
-176,437
-59% -$8.47M 0.01% 893
2020
Q1
$12.7M Sell
299,791
-108,130
-27% -$4.46M 0.03% 551
2019
Q4
$17.5M Buy
407,921
+13,739
+3% +$598K 0.03% 635
2019
Q3
$14.2M Buy
394,182
+179,378
+84% +$5.44M 0.02% 671
2019
Q2
$5.74M Buy
214,804
+167,730
+356% +$4.28M 0.01% 1082
2019
Q1
$1.26M Buy
47,074
+34,625
+278% +$809K ﹤0.01% 1792
2018
Q4
$201K Buy
12,449
+949
+8% +$18.4K ﹤0.01% 2248
2018
Q3
$239K Sell
11,500
-140
-1% -$2.2K ﹤0.01% 2272
2018
Q2
$178K Sell
11,640
-111,920
-91% -$2M ﹤0.01% 2355
2018
Q1
$2.78M Sell
123,560
-110,700
-47% -$3.06M ﹤0.01% 1435
2017
Q4
$7.3M Buy
234,260
+59,799
+34% +$1.91M 0.01% 1009
2017
Q3
$6.57M Sell
174,461
-9,999
-5% -$325K 0.01% 1036
2017
Q2
$5.14M Buy
184,460
+13,400
+8% +$399K 0.01% 1125
2017
Q1
$5.88M Sell
171,060
-27,670
-14% -$977K 0.01% 1062
2016
Q4
$5.73M Buy
198,730
+190,272
+2,250% +$5.03M 0.01% 1055
2016
Q3
$269K Buy
8,458
+400
+5% +$13.6K ﹤0.01% 2163
2016
Q2
$262K Buy
8,058
+428
+6% +$14.3K ﹤0.01% 2142
2016
Q1
$213K Buy
7,630
+300
+4% +$6.54K ﹤0.01% 2183
2015
Q4
$261K Sell
7,330
-420
-5% -$14.8K ﹤0.01% 2095
2015
Q3
$256K Buy
7,750
+100
+1% +$4.16K ﹤0.01% 2083
2015
Q2
$320K Sell
7,650
-100
-1% -$3.87K ﹤0.01% 2049
2015
Q1
$253K Hold
7,750
﹤0.01% 2101
2014
Q4
$246K Sell
7,750
-700
-8% -$19.9K ﹤0.01% 2074
2014
Q3
$209K Sell
8,450
-8,200
-49% -$192K ﹤0.01% 2119
2014
Q2
$376K Buy
16,650
+8,200
+97% +$171K ﹤0.01% 2111
2014
Q1
$206K Buy
8,450
+300
+4% +$7.59K ﹤0.01% 2158
2013
Q4
$204K Buy
+8,150
New +$192K ﹤0.01% 2178
2013
Q3
Sell
-17,546
Closed -$318K 2282
2013
Q2
$318K Buy
+17,546
New +$242K ﹤0.01% 2045

Other funds holding ACAD